The MRA spironolactone has been shown to prevent VC in both chronic kidney disease (CKD) rats and Klotho-deficient mice, likely through attenuation of MR signaling, local inflammation, osteogenic transdifferentiation, and apoptosis.665. Here, NR3C2 is linked to chronic kidney disease.